公开(公告)号：EP3923295A1

公开(公告)日：2021-12-15

申请号：EP21168039.2

申请日：2010-08-31

申请人： Abbott Diabetes Care, Inc.

发明人： BERNSTEIN, Daniel, Milfred ,  FENNELL, Martin, J. ,  SLOAN, Mark, Kent ,  LOVE, Michael ,  HE, Lei ,  THOMAS, Christopher, Allen ,  HOSS, Udo ,  FELDMAN, Benjamin, J. ,  DONIGER, Kenneth, J. ,  STAFFORD, Gary, Ashley ,  HAYTER, Gary, Alan ,  YEE, Phillip ,  KIAIE, Namvar ,  COLE, Jean-Pierre ,  DINH, Hung ,  TAUB, Marc, Barry ,  PACE, Louis ,  SICURELLO, Jeffrey, Mario

IPC分类号： G16H40/00

摘要： Methods and devices to monitor an analyte in body fluid are provided Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user Embodiments include wirelessly communicating analyte level information from on body electronics device to a second device such as a display device, and an analyte sensor comprising one or more storage devices such as non-volatile memory and other discrete components.

公开(公告)号：EP4252639A3

公开(公告)日：2024-01-03

申请号：EP23192566.0

申请日：2010-02-26

申请人： Abbott Diabetes Care Inc.

发明人： THOMAS, Christopher, Allen ,  HOSS, Udo ,  MCGARRAUGH, Geoffrey ,  HAYTER, Gary, Alan

IPC分类号： A61B5/145

摘要： Methods and systems for providing continuous analyte monitoring including in vivo sensors that do not require any user calibration during in vivo use are provided. Also provided are methods and devices including continuous analyte monitoring systems that include in vivo sensors which do not require any system executed calibration or which do not require any factory based calibration, and which exhibit stable sensor sensitivity characteristics. Methods of manufacturing the no calibration sensors and post manufacturing packaging and storage techniques are also provided.

公开(公告)号：EP2400886A1

公开(公告)日：2012-01-04

申请号：EP10746954.6

申请日：2010-02-26

申请人： Abbott Diabetes Care Inc.

发明人： THOMAS, Christopher, Allen ,  HOSS, Udo ,  MCGARRAUGH, Geoffrey, V. ,  HAYTER, Gary, Alan

IPC分类号： A61B5/05

CPC分类号： A61B5/1495 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/1473 ,  A61B5/1486 ,  A61B5/14865 ,  A61B2560/0223 ,  A61B2562/125 ,  G01N27/3272 ,  G01N27/3274

摘要： Methods and systems for providing continuous analyte monitoring including
in vivo sensors that do not require any user calibration during in vivo use are provided. Also provided are methods and devices including continuous analyte monitoring systems that include
in vivo sensors which do not require any system executed calibration or which do not require any factory based calibration, and which exhibit stable sensor sensitivity characteristics. Methods of manufacturing the no calibration sensors and post manufacturing packaging and storage techniques are also provided.

公开(公告)号：EP4252638A3

公开(公告)日：2024-01-03

申请号：EP23192559.5

申请日：2010-02-26

申请人： Abbott Diabetes Care, Inc.

发明人： THOMAS, Christopher, Allen ,  HOSS, Udo ,  MCGARRAUGH, Geoffrey ,  HAYTER, Gary, Alan

IPC分类号： A61B5/145

摘要： Methods and systems for providing continuous analyte monitoring including in vivo sensors that do not require any user calibration during in vivo use are provided. Also provided are methods and devices including continuous analyte monitoring systems that include in vivo sensors which do not require any system executed calibration or which do not require any factory based calibration, and which exhibit stable sensor sensitivity characteristics. Methods of manufacturing the no calibration sensors and post manufacturing packaging and storage techniques are also provided.

公开(公告)号：EP4252638A2

公开(公告)日：2023-10-04

申请号：EP23192559.5

申请日：2010-02-26

申请人： Abbott Diabetes Care, Inc.

发明人： THOMAS, Christopher, Allen ,  HOSS, Udo ,  MCGARRAUGH, Geoffrey ,  HAYTER, Gary, Alan

IPC分类号： A61B5/05

摘要： Methods and systems for providing continuous analyte monitoring including in vivo sensors that do not require any user calibration during in vivo use are provided. Also provided are methods and devices including continuous analyte monitoring systems that include in vivo sensors which do not require any system executed calibration or which do not require any factory based calibration, and which exhibit stable sensor sensitivity characteristics. Methods of manufacturing the no calibration sensors and post manufacturing packaging and storage techniques are also provided.

公开(公告)号：EP3912551A1

公开(公告)日：2021-11-24

申请号：EP21184415.4

申请日：2010-02-26

申请人： Abbott Diabetes Care, Inc.

发明人： THOMAS, Christopher, Allen ,  HOSS, Udo ,  MCGARRAUGH, Geoffrey ,  HAYTER, Gary, Alan

IPC分类号： A61B5/05

摘要： Methods and systems for providing continuous analyte monitoring including in vivo sensors that do not require any user calibration during in vivo use are provided. Also provided are methods and devices including continuous analyte monitoring systems that include in vivo sensors which do not require any system executed calibration or which do not require any factory based calibration, and which exhibit stable sensor sensitivity characteristics. Methods of manufacturing the no calibration sensors and post manufacturing packaging and storage techniques are also provided.

公开(公告)号：EP3714788A1

公开(公告)日：2020-09-30

申请号：EP20154429.3

申请日：2010-02-26

申请人： Abbott Diabetes Care, Inc.

发明人： THOMAS, Christopher, Allen ,  HOSS, Udo ,  MCGARRAUGH, Geoffrey ,  HAYTER, Gary, Alan

IPC分类号： A61B5/145

摘要： Methods and systems for providing continuous analyte monitoring including in vivo sensors that do not require any user calibration during in vivo use are provided. Also provided are methods and devices including continuous analyte monitoring systems that include in vivo sensors which do not require any system executed calibration or which do not require any factory based calibration, and which exhibit stable sensor sensitivity characteristics. Methods of manufacturing the no calibration sensors and post manufacturing packaging and storage techniques are also provided.

公开(公告)号：EP2473963A1

公开(公告)日：2012-07-11

申请号：EP10812438.9

申请日：2010-08-31

申请人： Abbott Diabetes Care, Inc.

发明人： BERNSTEIN, Daniel, Milfred ,  FENNELL, Martin, J. ,  SLOAN, Mark, Kent ,  LOVE, Michael ,  HE, Lei ,  THOMAS, Christopher, Allen ,  HOSS, Udo ,  FELDMAN, Benjamin, J. ,  DONIGER, Kenneth, J. ,  STAFFORD, Gary, Ashley ,  HAYTER, Gary, Alan ,  YEE, Phillip ,  KIAIE, Namvar ,  COLE, Jean-Pierre ,  DINH, Hung ,  TAUB, Marc, Barry ,  PACE, Louis ,  SICURELLO, Jeffrey, Mario

IPC分类号： G06Q50/00

CPC分类号： A61B5/0017 ,  A61B5/0022 ,  A61B5/01 ,  A61B5/14532 ,  A61B5/1486 ,  A61B5/72 ,  A61B2560/0238 ,  G01N33/48792 ,  G06F19/00 ,  G06F19/3418 ,  G06Q50/22 ,  Y02A90/22 ,  Y02A90/26

摘要： Methods and devices to monitor an analyte in body fluid are provided Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user Embodiments include wirelessly communicating analyte level information from on body electronics device to a second device such as a display device, and an analyte sensor comprising one or more storage devices such as non-volatile memory and other discrete components.

公开(公告)号：EP2473422A1

公开(公告)日：2012-07-11

申请号：EP10812728.3

申请日：2010-08-30

申请人： Abbott Diabetes Care, Inc.

发明人： HARPER, Wesley, Scott ,  TAN, Annie, C. ,  DUNN, Timothy, Christian ,  SLOAN, Mark, Kent ,  DONIGER, Kenneth, J. ,  MCGARRAUGH, Geoffrey, V. ,  LOVE, Michael ,  YEE, Phillip ,  HAYTER, Gary, Alan ,  TAUB, Marc, Barry ,  PEYSER, Thomas, A. ,  PANI, Michael, A. ,  JENNEWINE, Curtis, R. ,  BERMAN, Glenn, Howard

IPC分类号： B65D81/00

CPC分类号： A61B5/743 ,  A61B5/14532 ,  A61B5/7275 ,  A61B5/7282 ,  A61B5/7425 ,  A61B5/7435 ,  A61B5/7445 ,  A61B5/746 ,  A61B5/748 ,  A61B2560/045 ,  A61B2562/0295 ,  G06F19/00 ,  G06F19/3468 ,  G16H40/63

摘要： Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.

公开(公告)号：EP4420603A2

公开(公告)日：2024-08-28

申请号：EP24169003.1

申请日：2014-03-15

申请人： Abbott Diabetes Care, Inc.

发明人： BUDIMAN, Erwin, Satrya ,  HAYTER, Gary, Alan ,  DONIGER, Kenneth ,  DUNN, Timothy, Christian ,  CROUTHER, Nathan, Christopher ,  BERMAN, Glenn, Howard ,  WOLPERT, Howard

IPC分类号： A61B5/00

CPC分类号： G01N33/66 ,  A61B5/746 ,  A61B5/14532 ,  A61B5/4836 ,  G16H50/30 ,  G16H15/00 ,  G16Z99/00 ,  A61B5/7275

摘要： A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.